Grace Colon is listed as an executive officer and director on 10 SEC Form D filings by 3 issuers between Sep 2013 and Oct 2020: InCarda Therapeutics, Inc. (Newark, CA — pharmaceuticals — 2013–2020; $35.3M reported sold to 24 investors), Paradigm Diagnostics, Inc. (Phoenix, AZ — pharmaceuticals — 2017–2018; $11M reported sold to 12 investors) and PerceptiMed, Inc. (Mountain View, CA — other technology — 2015–2018; $5.35M reported sold to 8 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $51.6M sold in total.
Listed alongside Rodney S. Markin (4 shared filings), Carey Ng (3 shared filings), David Mallery (3 shared filings), David Neal (3 shared filings), Erin Curley (3 shared filings) and 22 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Grace. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 10 public filings for Grace Colon and found 13 differences, 1 worth asking the sponsor about: Form D filed 749 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.